These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 15167156)
1. Statistical approaches to handling uncertainty in health economic evaluation. Briggs AH Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):551-61. PubMed ID: 15167156 [TBL] [Abstract][Full Text] [Related]
2. Estimating uncertainty ranges for costs by the bootstrap procedure combined with probabilistic sensitivity analysis. Lord J; Asante MA Health Econ; 1999 Jun; 8(4):323-33. PubMed ID: 10398525 [TBL] [Abstract][Full Text] [Related]
3. [The handling of uncertainty in economic evaluations of health care strategies]. Siani C; Moatti JP Rev Epidemiol Sante Publique; 2003 Apr; 51(2):255-76. PubMed ID: 12876511 [TBL] [Abstract][Full Text] [Related]
4. Who's better not best: appropriate probabilistic uncertainty analysis. Coyle D Int J Technol Assess Health Care; 2003; 19(3):540-5. PubMed ID: 12962341 [TBL] [Abstract][Full Text] [Related]
5. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Briggs A; Sculpher M; Buxton M Health Econ; 1994; 3(2):95-104. PubMed ID: 8044216 [TBL] [Abstract][Full Text] [Related]
6. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran. Rezailashkajani M; Roshandel D; Shafaee S; Zali MR Dig Liver Dis; 2008 Jun; 40(6):412-7. PubMed ID: 18342588 [TBL] [Abstract][Full Text] [Related]
7. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care. O'Brien BJ; Drummond MF; Labelle RJ; Willan A Med Care; 1994 Feb; 32(2):150-63. PubMed ID: 8302107 [TBL] [Abstract][Full Text] [Related]
8. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials. Doshi JA; Glick HA; Polsky D Value Health; 2006; 9(5):334-40. PubMed ID: 16961551 [TBL] [Abstract][Full Text] [Related]
9. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Briggs A; Fenn P Health Econ; 1998 Dec; 7(8):723-40. PubMed ID: 9890333 [TBL] [Abstract][Full Text] [Related]
10. Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data. Willan AR; O'Brien BJ Health Econ; 1999 May; 8(3):203-11. PubMed ID: 10348415 [TBL] [Abstract][Full Text] [Related]
11. Sensitivity analysis in economic evaluation: a review of published studies. Briggs A; Sculpher M Health Econ; 1995; 4(5):355-71. PubMed ID: 8563834 [TBL] [Abstract][Full Text] [Related]
13. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Briggs AH; Goeree R; Blackhouse G; O'Brien BJ Med Decis Making; 2002; 22(4):290-308. PubMed ID: 12150595 [TBL] [Abstract][Full Text] [Related]
14. Incremental net benefit in the analysis of economic data from clinical trials, with application to the CADET-Hp trial. Willan AR Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):543-9. PubMed ID: 15167155 [TBL] [Abstract][Full Text] [Related]
15. Accounting for parameter uncertainty in the definition of parametric distributions used to describe individual patient variation in health economic models. Degeling K; IJzerman MJ; Koopman M; Koffijberg H BMC Med Res Methodol; 2017 Dec; 17(1):170. PubMed ID: 29246192 [TBL] [Abstract][Full Text] [Related]
16. At what price significance? The effect of price estimates on statistical inference in economic evaluation. Rittenhouse BE; Dulisse B; Stinnett AA Health Econ; 1999 May; 8(3):213-9. PubMed ID: 10348416 [TBL] [Abstract][Full Text] [Related]